Key Points

• Minnesota’s cannabis omnibus bill expands social equity investment limits to 33% ownership across four licenses.
• The new law eliminates the hemp-cannabis dual licensure prohibition and creates a new macrobusiness license for vertically integrated operators.
• A new “ratio hemp infused cannabis product” category (effective January 1, 2027) bridges the hemp and cannabis markets with defined THC and cannabinoid limits.

A Fundamental Restructuring

Minnesota has fundamentally restructured three pillars of the state’s cannabis framework with an omnibus bill that defines who can invest in social equity ventures, how businesses can operate across the hemp-cannabis divide and how aggressively the state can enforce compliance.

The majority of amendments took effect August 1, 2026, with the new macrobusiness license and conversion of existing medical cannabis combination businesses set to take effect on January 1, 2027.

Expanded Investment in Social Equity Licenses

Investors may now hold up to 33% controlling ownership of up to four social equity applicants or licensees — a dramatic expansion from the prior one-license-per-type limit. The bill amends Minn. Stat. § 342.185 to apply this rule to both applications (Subd. 2(iii)) and issued licenses (Subd. 3(iii)). The existing carve-out for passive investors holding 10% or less remains intact, as does the allowance for up to 10 municipal cannabis store arrangements.

Practical Effect: This change substantially improves the ability of social equity applicants to attract meaningful investment by allowing larger investors to deploy capital across multiple ventures without triggering ownership restrictions.

Dual Licensure for Hemp and Cannabis Businesses

The bill eliminates the longstanding prohibition on holding both a hemp license and a cannabis business license. Amendments to Minn. Stat. §§ 342.43 and 342.44 remove the cross-licensing barriers from both sides, allowing hemp and cannabis operators to enter each other’s markets without forfeiting existing licenses.

Shared Premises. Minn. Stat. § 342.235 now permits cannabis and hemp businesses to occupy the same premises, provided they share the same majority owners in common (each individually owning more than 10%). Businesses sharing premises are jointly liable for any violations.

Practical Effect: Existing hemp operators can now enter the cannabis market—and vice versa—without surrendering current licenses. Combined with the shared-premises provision, this creates opportunities for vertical integration and reduced overhead across both markets.

New ‘Ratio Hemp Infused Cannabis Products’
(effective January 1, 2027)

The bill creates a new product category — “ratio hemp infused cannabis products” — bridging the hemp and cannabis markets. These products combine cannabis extracts with nonintoxicating, non-artificially derived hemp cannabinoids (as defined in 7 U.S.C. § 1639o(1)) approved by the Office of Cannabis Management (OCM).

THC Limits:

Edibles: maximum 10mg THC per serving and 200mg per package
Beverages: maximum 10mg THC per serving, maximum 2 servings per container
Transdermal/topical and vaporized products: limits to be set by OCM in rule

Cannabinoid Limits. CBD, CBG, CBN, and CBC are each capped at no more than 100mg per serving.

Practical Effect: This category creates a product niche leveraging both hemp- and cannabis-derived inputs, offering manufacturers a differentiated product line for consumers interested in broader cannabinoid profiles. Product categories must be approved by OCM.

OCM’s Expanded Enforcement Authority

The bill significantly expands OCM’s ability to deny, revoke and enforce licenses, creating a materially more aggressive regulatory posture:

Cross-Agency Disqualification. OCM can now treat civil or regulatory violations issued by other state agencies as disqualifying for cannabis or hemp licensure, and those agencies may release investigative data to OCM upon request (Minn. Stat. § 342.15 Subd. 5).

Criminal Disqualification Reform. The bill replaces rigid felony bars with a discretionary, rule-based approach—granting OCM rulemaking authority over which convictions disqualify applicants—and now requires OCM to set aside violations where mitigating factors exist (Minn. Stat. § 342.15 Subd. 2).

Unlicensed Business Enforcement. OCM gains expanded authority to inspect unlicensed premises, seize and embargo products, and assess civil penalties. Notably, possession of seized products can now be treated as a “sale” for penalty calculation (Minn. Stat. § 342.19 Subd. 6).

Local Government and Applicant Status. Local zoning compliance is now mandatory (not merely discretionary) for license issuance, and local governments can suspend retail registrations with penalties up to $2,000 per violation (Minn. Stat. § 342.14 Subd. 6). Separately, qualified applicant status now expires after six months, allowing OCM to reassess market saturation periodically (Subd. 3).

Practical Implication: The enforcement landscape is materially more aggressive. Licensees and applicants must ensure compliance not only with cannabis-specific rules but with all civil and regulatory obligations across state agencies—any of which could now serve as independent grounds for disqualification.

New Macrobusiness License
(effective January 1, 2027)

The bill’s most significant structural change is the replacement of the “medical cannabis combination business” license with a new “cannabis macrobusiness” license (Section 103, amending Minn. Stat. § 342.515), creating a pathway for large-scale, vertically integrated operators.

Key features of the cannabis macrobusiness license include:

License Conversion.
All existing medical cannabis combination business licenses and pending applications convert to macrobusiness licenses by January 1, 2027. The bill caps macrobusiness licenses at eight prior to January 1, 2030 (including capacity for six existing applicants, two of which are already licensed).

Cultivation Limits.
Up to 38,000 square feet of indoor canopy initially, with incremental expansions at each renewal (2,000/2,000/3,000 sq. ft.). Outdoor cultivation is permitted up to one acre.

Manufacturing Capacity.
Macrobusinesses may manufacture up to 90,000 pounds of cannabis dry-weight equivalent (Subd. 3).

Retail Operations.
A macrobusiness may operate up to eight retail locations. If operating more than five locations, at least three must be situated in areas designated as high medical need (Subd. 4).

Medical Endorsement Requirement.
Macrobusinesses must obtain a medical cannabis manufacturing endorsement and at least one other medical endorsement, underscoring the legislature’s intent to maintain robust medical cannabis access.

Fees.
Application: $10,000; initial license: $20,000; renewal: $70,000.

Ownership Restrictions.
Macrobusiness licensees are prohibited from owning other cannabis or hemp businesses, except that they may also hold a cannabis event organizer license (Subd. 8).

Reclassification Pathway.
Section 14 of the bill creates a pathway for mezzobusiness licensees to reclassify to macrobusiness status after two years of operation with a medical cultivation endorsement and at least one medical manufacturing or retail endorsement, provided the licensee is in good standing and has not been reclassified in the prior 12 months.

Takeaways

In light of these amendments, industry participants should consider the following:

• Social Equity Applicants
  Explore new capital-raising strategies under the expanded 33%/four-license framework. Investors should note this as a new avenue into the Minnesota cannabis space.
• Medical Cannabis Combination Businesses
  Prepare for mandatory conversion to macrobusiness licenses by January 1, 2027, including medical endorsement requirements and retail location strategy.
• Hemp Businesses
  Evaluate dual licensure and shared-premises opportunities to reduce operational costs and access the cannabis market.
• All Applicants and Licensees
  Audit compliance across all state regulatory obligations—not just cannabis-specific rules—given OCM’s expanded disqualification authority.
• Mezzobusiness Licensees
  Consider the reclassification pathway to macrobusiness status, available after two years of operation with qualifying medical endorsements.

For more information, please contact JT Schuweiler at jschuweiler@foxrothschild.com, Paul Fling at pfling@foxrothschild.com, or another member of Fox Rothschild’s national Cannabis Law Practice.

This information is intended to inform firm clients and friends about legal developments, including the decisions of courts and administrative bodies. Nothing in this alert should be construed as legal advice or a legal opinion. Readers should not act upon the information contained in this alert without seeking the advice of legal counsel. Views expressed are those of the authors and not necessarily this law firm or its clients.